Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) is held by 216 institutional investors per 13F filings through December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 31 Dec, 2025 | 0 | -11,044 | -2.41% | $0.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 0 | 49,802 | 1.63% | $0.00 |
| Rockefeller Capital Management L.P. | 31 Dec, 2025 | 0 | 7,154,317 | 4,125.00% | $0.00 |
| BAKER BROS. ADVISORS LP | 31 Dec, 2025 | 0 | 1,577 | 0.06% | $0.00 |
| Rubric Capital Management LP | 31 Dec, 2025 | 0 | -671,347 | -16.78% | $0.00 |
| Barclays Plc | 31 Dec, 2025 | 0 | -67,405 | -93.64% | $0.00 |
| TANG CAPITAL MANAGEMENT LLC | 31 Dec, 2025 | 0 | -68,720 | -2.95% | $0.00 |
| Fairmount Funds Management LLC | 31 Dec, 2025 | 0 | -453,151 | -25.56% | $0.00 |
| ACADIAN ASSET MANAGEMENT LLC | 31 Dec, 2025 | 0 | 94,522 | 5.84% | $0.00 |
| Point72 Asset Management, L.P. | 31 Dec, 2025 | 0 | 230,210 | 40.61% | $0.00 |
| FMR LLC | 31 Dec, 2025 | 0 | 843,108 | 105.42% | $0.00 |
| Pictet Asset Management Holding SA | 31 Dec, 2025 | 0 | -144,576 | -15.51% | $0.00 |
| Morgan Stanley | 31 Dec, 2025 | 0 | -2,879 | -0.21% | $0.00 |
| Qube Research & Technologies Ltd | 31 Dec, 2025 | 0 | 76,403 | 11.07% | $0.00 |
| D. E. Shaw & Co., Inc. | 31 Dec, 2025 | 0 | 107,435 | 9.47% | $0.00 |
| Soleus Capital Management, L.P. | 31 Dec, 2025 | 0 | 437,000 | 291.33% | $0.00 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 31 Dec, 2025 | 0 | -47 | 0.00% | $0.00 |
| Spruce Street Capital LP | 31 Dec, 2025 | 0 | 434,982 | 0.00% | $0.00 |
| BNP PARIBAS FINANCIAL MARKETS | 31 Dec, 2025 | 0 | 178,366 | 27.30% | $0.00 |
| Aberdeen Group plc | 31 Dec, 2025 | 0 | 241,876 | 152.39% | $0.00 |